SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wintac receives USFDA approval for manufacturing plant at Bangalore

03 May 2014 Evaluate

Wintac has received the USFDA approval for the manufacturing plant located at Nelamangala, Bangalore and thus the Warning Letter issued to the company during February 2012 on certain GMP issues gets vacated. The said plant manufactures pharmaceutical formulations - sterile injections and ophthalmic products.

Wintac range of specialties includes Antifungal, Anticancer, Cardiovascular, Corticosterid, Antiemetic, Large and small volume injectable and ophthalmic solutions.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×